Oncoinvent has published Phase 1 dosimetry data for Radspherin in [...]

A new AI model has generated patient-specific radiation dose-rate maps [...]

Enterome Phase 1/2 data show EO2463-induced CD8 T-cell expansion was [...]

Telix has dosed the first patient in a Phase 3 [...]

Patients across South Florida are set to gain greater access [...]

The UK is launching a major programme to convert used [...]

VIVES Partners, managing company of VIVES Funds, has joined a [...]

Orano Med has expanded its US research and development center [...]

Meitheal introduces albumin-bound injectable version under license from Hong Kong [...]

A new international alliance, CAR T Vision, launched today with [...]